Avalon GloboCare: Jumps on distribution rights for COVID-19 test kit

Change Agents

19/08/2020 15:58

** Shares of drug developer  AVCO.O  rise 21% to $1.90 in
morning trade
    ** Co enters into a commercialization partnership agreement
with North Carolina-based diagnostic tests manufacturer Cellex
Inc  urn:newsml:reuters.com:*:nGNX2ZtbfY
    ** AVCO gets distribution rights to market Cellex's COVID-19
antibody-based rapid test kit both in the United States and
internationally
    ** The test kits can detect antibodies specific to the
SARS-CoV-2 that causes COVID-19 within 15 minutes
    ** AVCO down 2.59% YTD
    

 (Reporting by Shivani Kumaresan in Bengaluru)
 ((Shivani.Kumaresan@thomsonreuters.com ; +1 646 223 8780))